Finance

Lists
RICH:BCBA
Laboratorios Richmond SACIF
ARS 1,495.00
+0.34%
(+5.00) 1D
Oct 16, 4:38:54 PM GMT-3  ·   ARS
All symbols
SymbolPriceChange% Change
Generating top insights for RICH...
Mkt. cap
21.11B
Avg. vol.
0.00
Volume
0.00
Dividend
1.10%
Quarterly dividend
ARS 4.13
Ex-dividend date
Jun 12, 2026
P/E ratio
9.89
52-wk high
ARS 2,300.00
52-wk low
ARS 1,070.00
EPS
ARS 151.20
Shares outstanding
14.17M
No. of employees
620
Mkt. cap
21.11B
Avg. vol.
0.00
Volume
0.00
Dividend
1.10%
Quarterly dividend
ARS 4.13
Ex-dividend date
Jun 12, 2026
P/E ratio
9.89
52-wk high
ARS 2,300.00
52-wk low
ARS 1,070.00
EPS
ARS 151.20
Shares outstanding
14.17M
No. of employees
620
News stories
From web sources and news partners
About Laboratorios Richmond SACIF
CEO-
Employees620
FoundedMay 1, 1935
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in ARS
Loading Previous Earnings...
Revenue
Net income
All values in ARS
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
30.88B
-
30.69B
32.80B
Cost of goods sold
11.11B
-
13.81B
11.97B
Cost of revenue
11.11B
-
13.81B
11.97B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.00B
-
13.11B
14.74B
Operating expense
12.28B
-
16.71B
19.87B
Total operating expenses
23.38B
-
30.53B
31.85B
Operating income
7.49B
-
161.44M
951.60M
Other non operating income
2.64B
-
27.71B
-752.76M
EBT including unusual items
-8.41B
-
25.16B
-8.38B
EBT excluding unusual items
1.72B
-
25.16B
-8.58B
Income tax expense
809.23M
-
2.51B
-866.74M
Effective tax rate
-9.63%
-
9.97%
10.35%
Other operating expenses
274.11M
-
3.60B
5.13B
Net income
-9.17B
-
22.59B
-8.65B
Net profit margin
-29.70%
-
73.61%
-26.38%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-3.66B
-
-5.32B
-5.42B
Net interest expenses
-3.66B
-
-5.32B
-5.42B
Depreciation and amortization charges
-
-
-
-
EBITDA
8.32B
-
1.36B
3.61B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps